Skip to main content

Full coverage

Abbott agrees to settlement over closure of largest baby formula plant in the US

5 sources|Diversity: 61%Right blind spot|

By Extra Extra Editorial

Cross-spectrum analysis, synthesized with AI from 5 sources · Updated

How we analyze coverage

Abbott Laboratories has agreed to settle a Department of Justice lawsuit stemming from contamination issues at its Michigan baby formula manufacturing facility, which was shuttered in 2022. The closure created a significant supply shortage in the U.S. infant formula market during a period of already-constrained availability. The settlement resolves federal allegations regarding safety lapses at what had been the nation's largest formula production site. The agreement marks a resolution to litigation that began after the facility's contamination problems became public.

Left· 2 sources

Left-leaning outlets emphasize the settlement as a necessary consequence of Abbott's operational failures and frame it within the context of the broader formula shortage that strained families nationwide. These sources highlight the company's accountability and the significance of the largest U.S. formula plant being offline during a critical supply crisis.

Center· 3 sources

Center outlets present the settlement as a straightforward legal resolution to contamination allegations, focusing on the factual details of the DOJ action and Abbott's agreement. This coverage treats the story primarily as a regulatory and corporate accountability matter without extensive contextual framing.

Key Differences

  • Left outlets connect the settlement to the broader infant formula shortage crisis and its impact on families, while center sources focus narrowly on the legal resolution itself.
  • Right-leaning media shows no coverage of the Abbott settlement, creating a complete absence of conservative perspective on this corporate accountability matter.
  • Left sources emphasize Abbott's operational failures as systemic problems, whereas center coverage remains more neutral and procedural in tone.

How this story is being covered

5 reports from 5 outlets61/100 cross-spectrum diversityNo right-leaning coverage yet5 high-reliability sources

Extra Extra has grouped 5 reports on this story from 5 news outlets across the political spectrum. By political lean, that breaks down as 2 left-leaning and 3 center sources.

Its coverage-diversity score of 61 out of 100 means the story is being reported across multiple parts of the spectrum, though the volume leans toward one side. Notably, no right-leaning outlet in our index has picked the story up yet — a right-side blind spot that often signals a topic resonating more with progressive audiences.

On reliability, 5 of the 5 rated outlets carry a high or mostly-factual reliability rating (A or B). Ratings are drawn from independent assessments and are meant to help you weigh each report, not to tell you which to trust.

Coverage of this story has developed over roughly 23 hours, so the perspectives below capture how the framing shifted as the story matured.

Below, the same story is laid out side by side as left, center, and right outlets reported it. Read across the columns and watch what changes: the headline emphasis, which facts lead, the adjectives, and what each side leaves out. The story itself rarely changes — the framing almost always does.

Outlets covering this story: ABC News, New York Times, The Hill, Route Fifty, The Texas Tribune.


Left(2)

Center(3)

Right(0)

No right-leaning sources covered this story

Get this analysis in your inbox

The Daily Spectrum: one email, three perspectives on the day's biggest stories.

Free forever. Unsubscribe anytime. No spam.

New to comparing coverage? Start with our guides to reading the news critically.

Back to Compare